Skip to main content

Published locations for Advanced NSCLC: Adding antiangiogenic drug to second-line therapy boosts survival outcomes

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Advanced NSCLC: Adding antiangiogenic drug to second-line therapy boosts survival outcomes

User login

  • Reset your password
  • /content/advanced-nsclc-adding-antiangiogenic-drug-second-line-therapy-boosts-survival-outcomes
  • /hematology-oncology/article/254069/lung-cancer/advanced-nsclc-adding-antiangiogenic-drug-second-line